Table: Towa Pharmaceutical -2024/25 group results

TOWA PHARMACEUTICAL

15/05/2025 07:39

May 15 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          259.59          227.93         280.00        134.50   
               (+13.9 pct)                    (+7.9 pct)    (+9.0 pct) 
  Operating       23.24           17.65          27.00         12.00   
               (+31.7 pct)                    (+16.2 pct)  (+14.1 pct) 
  Recurring       26.15           24.48          25.30         11.10   
               (+6.8 pct)                     (-3.3 pct)    (+7.4 pct) 
  Net
  Net             18.99           16.17          17.70          8.00   
               (+17.4 pct)                    (-6.8 pct)   (+22.0 pct) 
  EPS          385.71 yen      328.59 yen     359.57 yen    162.52 yen 
  Ann Div       70.00 yen       60.00 yen      80.00 yen               
  -Q2 Div       30.00 yen       30.00 yen      40.00 yen               
  -Q4 Div       40.00 yen       30.00 yen      40.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T